Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.40
-0.18 (-3.23%)
Mar 31, 2025, 12:17 PM EDT - Market open
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $831.28 million as of March 31, 2025. Its market cap has increased by 171.49% in one year.
Market Cap
831.28M
Enterprise Value
1.06B
1-Year Change
171.49%
Ranking
Category
Stock Price
$5.40
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $831.28M, an increase of 181.05%. That is a compound annual growth rate of 34.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 858.99M | 69.97% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.49B |
| UnitedHealth Group | 474.41B |
| Johnson & Johnson | 395.07B |
| AbbVie | 364.22B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 227.76B |
| Merck & Co. | 225.89B |
| AstraZeneca | 225.00B |